+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice

Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice

Plos One 8(9): E74729

IL-10 is a cytokine that regulates the balance between pathogen clearance and immunopathology. Brucella abortus is an intracellular bacterium that causes chronic disease in humans and domestic animals. Here we evaluated the contribution of IL-10 in host immune response and pathology during B. abortus infection. To assess the role of IL-10 in vivo, IL-10 knockout (KO) or 129 Sv/Ev (wild-type) mice were infected with B. abortus and the number of viable bacteria from the spleen was determined at 1, 2, 3, 6 and 14-weeks postinfection. IL-10 KO mice showed reduced bacterial loads in the spleen when compared to wild-type mice during all time points studied. Additionally, at 14-weeks postinfection IL-10 KO mice had totally cleared the infection. This clearance was preceded by an enhanced IFN-γ, TNF-α and IL-17 responses in both the serum and the spleen of IL-10 KO mice. Additionally, dendritic cells from infected IL-10 KO mice produced elevated levels of IL-12 and TNF-α compared to wild-type animals. Histopathology analysis was performed and both KO and wild-type mice developed multifocal granulomas and necrosis in the liver. However, at six-weeks postinfection reduced numbers of granulomas was detected in IL-10 KO mice compared to wild-type animals. This reduced liver pathology at later stage of infection was accompanied by increased numbers of CD4+CD25+foxp3+ T cells and expression of TGF-β in IL-10 KO splenocytes. Taken together, our findings demonstrate that IL-10 modulates the proinflammatory immune response to B. abortus infection and the lack of IL-10 increases resistance to Brucella infection.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 054063228

Download citation: RISBibTeXText

PMID: 24069337

Related references

Depletion of Complement Enhances the Clearance of Brucella abortus in Mice. Infection and Immunity 86(10), 2018

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infection and Immunity 62(11): 4990-4996, 1994

Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice. Infection and Immunity 74(7): 4048-4057, 2006

NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus. European Journal of Immunology 47(1): 51-59, 2016

Treatment of mice with staphylococcal enterotoxin B enhances resolution of an induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines. Infection and Immunity 66(6): 2466-2470, 1998

Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection. Journal of Microbiology and Biotechnology 26(1): 190-196, 2016

Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice. Journal of Veterinary Science 13(3): 287-292, 2013

T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. European Journal of Immunology 8(7): 459-463, 1978

Substantial protective immunity conferred by a combination of Brucella abortus recombinant proteins; SodC, RibH, Ndk, L7/L12 and MDH against Brucella abortus 544 infection in BALB/c mice. Journal of Microbiology and Biotechnology 2019, 2019

Variation in Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19. Infection & Immunity 64(2): 548-556, 1996

Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide. Roumanian Archives of Microbiology and Immunology 69(1): 5-12, 2010

Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus. Vaccine 36(21): 3027-3033, 2018

Effect of passive immunisation against Brucella abortus on active production of Brucella abortus agglutinins in young rats. Journal of Pathology and Bacteriology 96(1): 137-148, 1968

Lipopolysaccharide lps from brucella abortus is less toxic than that from escherichia coli suggesting the possible use of brucella abortus or lps from brucella abortus as a carrier in vaccines. Infection & Immunity 60(4): 1385-1389, 1992

Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine 8(5): 462-468, 1990